Confounders of Cardioprotection by Remote Ischemic Preconditioning in Patients Undergoing Coronary Artery Bypass

Petra Kleinbongard1, Markus Neuhäuser, Matthias Thielmann

  • 1Institute for Pathophysiology, West German Heart and Vascular Center Essen, University Hospital Essen, Essen, Germany.

Cardiology
|November 5, 2015
PubMed

Insights

Remote ischemic conditioning (RIC) protects the heart during coronary artery bypass grafting (CABG). Longer aortic cross-clamp times amplify RIC

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Ischemic Conditioning

Background:

  • Remote ischemic conditioning (RIC) offers cardioprotection in coronary artery bypass grafting (CABG).
  • Potential confounding factors like patient risk, comorbidities, and medications may affect RIC's efficacy.
  • Identifying these confounders is crucial for optimizing RIC's protective effects.

Purpose of the Study:

  • To identify patient-related and intraoperative factors that may attenuate the cardioprotective effects of RIC during CABG.
  • To analyze the impact of demographics, medications, and surgical variables on myocardial injury post-CABG with RIC.

Main Methods:

  • Retrospective analysis of a single-center, randomized, double-blind trial involving patients undergoing elective CABG.
  • Evaluation of demographics, medications (beta-blockers, statins, ACE inhibitors, ARBs), and intraoperative variables.
  • Primary endpoint: myocardial injury assessed by serum troponin I (TnI) levels up to 72 hours post-surgery.

Main Results:

  • Age and aortic cross-clamp time were significant factors influencing troponin I release.
  • RIC demonstrated protection across all age groups.
  • RIC-induced protection was evident with aortic cross-clamp times of 57-75 minutes and ≥76 minutes, but not ≤56 minutes.
  • Gender, beta-blockers, statins, ACE inhibitors, ARBs, and intraoperative nitroglycerine did not impact RIC's cardioprotective effect.

Conclusions:

  • Age and aortic cross-clamp duration are key determinants in RIC-mediated cardioprotection during CABG.
  • Commonly used medications and patient demographics do not significantly alter RIC's protective benefits.
  • Extended cross-clamp times, leading to greater ischemia-reperfusion injury, enhance the detectability of RIC's cardioprotective effects.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.9K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
960
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
841
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
400
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
450